TrialArthritis & rheumatology (Hoboken, N.J.)2021

Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study.

Pierre Quartier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.